Companies · Biotechnology

BullFrog AI Holdings, Inc.

GAITHERSBURG · Biotechnology

Diligence memoA one-page analyst read on BullFrog AI Holdings, Inc. — recommendation, valuation, rhythm, risks.
$866K
Total raised · real
1
Rounds
Latest step-up
Top 85%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Fri Apr 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

BullFrog AI Holdings, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 4.78× the median modeled value of Pre-Seed Biotechnology companies in 2022–2024 (185 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.2 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

BullFrog AI Holdings, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.2 yr record
Peak capital year was 2022 with $866K across 1 filings.
Market position
ahead of 16% of Biotechnology peers
Capital scale is ahead of 16% of Biotechnology peers; modeled value is above 25% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $866K across 1 filings.
  • Largest single filing was $866K on 2022-04-29.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

BullFrog AI Holdings, Inc. is one of 4293 Biotechnology companies tracked from GAITHERSBURG. By capital raised it ranks in the long tail (ahead of 16% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

ai/ml

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2020
Year incorporated
2022-04-29
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2022-04-29 Raised $866K (real) Modeled valuation $15M (est)$866K$15MPre-Seed2022

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$866K · 2022

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$15.4M
Base estimate est.
$462K
Conservative case
$100.4M
Upside case
$4.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
24%
Survival probability
10% low · 44% high
1.86×/yr
Annual markup
2.52×/yr upside case
4.2 yr
Elapsed time used
4.2 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
4.2 yr
On record since
2022
First round
1
Rounds on file
How it compares to the market

Benchmarked against 4293 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$866K
Sector median$7.2M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 2.1× above median
This company$866K
Sector median$412K
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$15.4M
Sector median$64.2M

Raised more than 16% of sector peers (real $). Modeled value above 25% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #3 of 185.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)TissueMill Technologies LLC · Pre-Seed Raised $1.0M · modeled $18.3M (est)Aldebaran Therapeutics, Inc. · Pre-Seed Raised $800K · modeled $16.3M (est)Vesicle Therapeutics Inc. · Pre-Seed Raised $800K · modeled $14.8M (est)TAUC3 Biologics Ltd · Pre-Seed Raised $839K · modeled $14.4M (est)UCHU Biosensors, Inc. · Pre-Seed Raised $828K · modeled $13.1M (est)BackStop Neural, Inc. · Pre-Seed Raised $884K · modeled $12.9M (est)Virocell Biologics Ltd · Pre-Seed Raised $993K · modeled $12.9M (est)PurCell Bio, Inc · Pre-Seed Raised $841K · modeled $12.6M (est)MicroVizual Inc. · Pre-Seed Raised $750K · modeled $12.0M (est)NeuroX Innovations Inc. · Pre-Seed Raised $1.2M · modeled $11.9M (est)NeuroDex Inc · Pre-Seed Raised $1.3M · modeled $11.8M (est)BullFrog AI Holdings, Inc. (this company) Raised $866K · modeled $15.4M (est)BullFrog AI Holdings, Inc.
CompanyStageRaised · realValue · estvs peer med.
TissueMill Technologies LLCPre-Seed$1.0M$18.3M5.66×
Aldebaran Therapeutics, Inc.Pre-Seed$800K$16.3M5.05×
BullFrog AI Holdings, Inc. this companyPre-Seed$866K$15.4M4.78×
Vesicle Therapeutics Inc.Pre-Seed$800K$14.8M4.60×
TAUC3 Biologics LtdPre-Seed$839K$14.4M4.48×
UCHU Biosensors, Inc.Pre-Seed$828K$13.1M4.07×
BackStop Neural, Inc.Pre-Seed$884K$12.9M4.01×
Virocell Biologics LtdPre-Seed$993K$12.9M4.00×
PurCell Bio, IncPre-Seed$841K$12.6M3.91×
MicroVizual Inc.Pre-Seed$750K$12.0M3.73×
NeuroX Innovations Inc.Pre-Seed$1.2M$11.9M3.69×
NeuroDex IncPre-Seed$1.3M$11.8M3.67×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$866K2022-04-29$4.8M$15.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$866K2022-04-29
    • First recorded raise — entered as Pre-Seed.
    • 7 investors on this round.
Intelligence
Modeled next raise
$1.4M
Modeled next size est.range $901K$2.2M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
VININDER SINGH1 other2022-04
Dane Saglia2022-04
Registry & provenance

BullFrog AI Holdings, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1829247
SEC CIK
2020
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Ascendance Biotechnology, Inc.BiotechnologyPre-Seed$880K$12.7Msame sector · same stage
Mensura Health Inc.BiotechnologyPre-Seed$850K$11.6Msame sector · same stage
BackStop Neural, Inc.BiotechnologyPre-Seed$884K$12.9Msame sector · same stage
Proteoform Scientific Inc.BiotechnologyPre-Seed$885K$15.2Msame sector · same stage
PurCell Bio, IncBiotechnologyPre-Seed$841K$12.6Msame sector · same stage
TAUC3 Biologics LtdBiotechnologyPre-Seed$839K$14.4Msame sector · same stage
Navisonics, Inc.BiotechnologyPre-Seed$835K$18.5Msame sector · same stage
BIO Wellness, Inc.BiotechnologyPre-Seed$902K$11.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
NanoSpot.ai, Inc.BiotechnologyPre-Seed$5.2M83%
AI Proteins, Inc.BiotechnologySeries A$30.0M82%
Bio-AI Health Inc.BiotechnologySeed$2.8M82%
Biostate AI, IncBiotechnologySeries A$14.7M81%
Genleap Ai Inc.BiotechnologySeries C$1.5B81%
Vitazi.AI, Inc.BiotechnologySeed$1.1M81%
Pathos AI, Inc.BiotechnologySeries D+$2.4B80%
Zephyr AI, Inc.BiotechnologySeries D+$1.5B80%
Frequently asked
How much funding has BullFrog AI Holdings, Inc. raised?
BullFrog AI Holdings, Inc. has raised approximately $866K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is BullFrog AI Holdings, Inc.'s estimated valuation?
Provath's modeled valuation for BullFrog AI Holdings, Inc. is approximately $15.4M (modeled range $462K–$100.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is BullFrog AI Holdings, Inc. at?
BullFrog AI Holdings, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Fri Apr 29.
What does BullFrog AI Holdings, Inc. do and where is it based?
BullFrog AI Holdings, Inc. operates in the Biotechnology sector, based in GAITHERSBURG.
Explore related

See where BullFrog AI Holdings, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at BullFrog AI Holdings, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.